Home > Inhibitors & Agonists > Antibiotics and Antivirals > Bacterial
Cat. No. Product name CAS No.
DC11768 TAM-16

A benzofuran class inhibitor of M. tuberculosis Pks13 (Polyketide Synthase 13).

2030241-59-7
DC11534 Sudoterb Featured

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL..

676266-31-2
DC11535 Sudoterb dihydrchloride

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL..

1044503-04-9
DC10513 AFN-1252(Debio 1452) Featured

AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml.

620175-39-5
DC9827 AN3365(Epetraborole) Featured

AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics.

1234563-16-6
DC10552 AU1235 Featured

AU1235 is an adamantyl urea inhibitor of Mycobacterium tuberculosis.

1338780-86-1
DCAPI1362 Azithromycin (Zithromax)

Azithromycin (Zithromax)

83905-01-5
DC8809 Bedaquiline fumarate Featured

Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis.

845533-86-0
DC4143 Besifloxacin HCl Featured

Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic.

405165-61-9
DC10393 Bicyclomycin benzoate

Bicyclomycin benzoate is an antibiotic exhibiting activity against a broad spectrum of Gram-negative bacteria and against the Gram-positive bacterium.

37134-40-0
DC9853 BM212 Featured

BM-212 is a potent antimycobacterial agent and MmpL3 inhibitor.

146204-42-4
DCAPI1024 Cefditoren pivoxil

Cefditoren pivoxil

117467-28-4
DC8937 Clarithromycin

Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.

81103-11-9
DC11061 ClpP inhibitor M21

ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM, inhibits ClpP cleavage of SUc-LY-AMC substrate in a peptidase assay.

1151944-58-9
DCAPI1493 Dalbavancin Featured

Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen.

171500-79-1
DC7764 Delamanid (OPC-67683) Featured

Delamanid (OPC-67683) is an experimental drug for the treatment of multi-drug-resistant tuberculosis.

681492-22-8
DC10612 Delpazolid (LCB01-0371) Featured

Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone.

1219707-39-7
DC9949 DprE1-IN-2 Featured

DprE1-IN-2 is a potent DprE1 inhibitor.

1615713-87-5
DC8440 Erythromycin Cyclocarbonate

Erythromycin Cyclocarbonate, derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome.

55224-05-0
DC9350 Faropenem daloxate

Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics.

141702-36-5
DC1057 Fidaxomicin (Dificid) Featured

Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics.

873857-62-6
DC8847 Finafloxacin (BAY35-3377)

Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments.

209342-40-5
Page 1 / Total 4 FirstPrevNextLastGoto